<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37020097</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>05</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Enhanced axonal regeneration of ALS patient iPSC-derived motor neurons harboring SOD1<sup>A4V</sup> mutation.</ArticleTitle><Pagination><StartPage>5597</StartPage><MedlinePgn>5597</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5597</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-31720-7</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, characterized by degeneration of upper and lower motor neurons that leads to muscle weakness, paralysis, and death, but the effects of disease-causing mutations on axonal outgrowth of neurons derived from human induced pluripotent stem cells (iPSC)-derived motor neurons (hiPSC-MN) are poorly understood. The use of hiPSC-MN is a promising tool to develop more relevant models for target identification and drug development in ALS research, but questions remain concerning the effects of distinct disease-causing mutations on axon regeneration. Mutations in superoxide dismutase 1 (SOD1) were the first to be discovered in ALS patients. Here, we investigated the effect of the SOD1<sup>A4V</sup> mutation on axonal regeneration of hiPSC-MNs, utilizing compartmentalized microfluidic devices, which are powerful tools for studying hiPSC-MN distal axons. Surprisingly, SOD1<sup>+/A4V</sup> hiPSC-MNs regenerated axons more quickly following axotomy than those expressing the native form of SOD1. Though initial axon regrowth was not significantly different following axotomy, enhanced regeneration was apparent at later time points, indicating an increased rate of outgrowth. This regeneration model could be used to identify factors that enhance the rate of human axon regeneration.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Katherine L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Neuromuscular Division, Department of Neurology, Johns Hopkins University School of Medicine, The John G. Rangos Sr. Building, Room 239, 855 N. Wolfe Street, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajbhandari</LastName><ForeName>Labchan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neuromuscular Division, Department of Neurology, Johns Hopkins University School of Medicine, The John G. Rangos Sr. Building, Room 239, 855 N. Wolfe Street, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venkatesan</LastName><ForeName>Arun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuromuscular Division, Department of Neurology, Johns Hopkins University School of Medicine, The John G. Rangos Sr. Building, Room 239, 855 N. Wolfe Street, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maragakis</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Neuromuscular Division, Department of Neurology, Johns Hopkins University School of Medicine, The John G. Rangos Sr. Building, Room 239, 855 N. Wolfe Street, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farah</LastName><ForeName>Mohamed H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Neuromuscular Division, Department of Neurology, Johns Hopkins University School of Medicine, The John G. Rangos Sr. Building, Room 239, 855 N. Wolfe Street, Baltimore, MD, 21205, USA. mfarah2@jhmi.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 NS130900</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS117608</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009416" MajorTopicYN="N">Nerve Regeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>7</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37020097</ArticleId><ArticleId IdType="pmc">PMC10076424</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-31720-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-31720-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Curr. Opin. Neurol. 2019 doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Glass JD. Axonal degeneration in motor neuron disease. Neurodegener. Dis. 2007;4:431&#x2013;442. doi: 10.1159/000107704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000107704</ArticleId><ArticleId IdType="pubmed">17934327</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, et al. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard JP, Maragakis NJ. Induced pluripotent stem cells from ALS patients for disease modeling. Brain Res. 2015 doi: 10.1016/j.brainres.2014.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.09.017</ArticleId><ArticleId IdType="pmc">PMC4362997</ArticleId><ArticleId IdType="pubmed">25223906</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrot J, Imhof S, Wainger BJ. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs. Neurobiol. Dis. 2020 doi: 10.1016/j.nbd.2019.104680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104680</ArticleId><ArticleId IdType="pmc">PMC7002167</ArticleId><ArticleId IdType="pubmed">31759135</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Huang EJ. Modeling ALS and FTD with iPSC-derived neurons. Brain Res. 2017;1656:88&#x2013;97. doi: 10.1016/j.brainres.2015.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.10.003</ArticleId><ArticleId IdType="pmc">PMC4833714</ArticleId><ArticleId IdType="pubmed">26462653</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 2014;7:1&#x2013;11. doi: 10.1016/j.celrep.2014.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.03.019</ArticleId><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014;14:781&#x2013;795. doi: 10.1016/j.stem.2014.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.03.004</ArticleId><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Egawa N, et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl. Med. 2012 doi: 10.1126/scitranslmed.3004052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3004052</ArticleId><ArticleId IdType="pubmed">22855461</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns AE, Maragakis NJ. Exploring motor neuron diseases using iPSC platforms. Stem Cells. 2022;40:2&#x2013;13. doi: 10.1093/stmcls/sxab006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/stmcls/sxab006</ArticleId><ArticleId IdType="pmc">PMC9199844</ArticleId><ArticleId IdType="pubmed">35511862</ArticleId></ArticleIdList></Reference><Reference><Citation>Okano H, Yasuda D, Fujimori K, Morimoto S, Takahashi S. Ropinirole, a new ALS drug candidate developed using iPSCs. Trends Pharmacol. Sci. 2020 doi: 10.1016/j.tips.2019.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2019.12.002</ArticleId><ArticleId IdType="pubmed">31926602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, et al. Effect of ezogabine on cortical and spinal motor neuron excitability in amyotrophic lateral sclerosis: A randomized clinical trial. JAMA Neurol. 2021;78:186&#x2013;196. doi: 10.1001/jamaneurol.2020.4300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.4300</ArticleId><ArticleId IdType="pmc">PMC7684515</ArticleId><ArticleId IdType="pubmed">33226425</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall KL, Farah MH. Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders. Neural Regen. Res. 2021;16:1901&#x2013;1910. doi: 10.4103/1673-5374.308077.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.308077</ArticleId><ArticleId IdType="pmc">PMC8343323</ArticleId><ArticleId IdType="pubmed">33642358</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinsell D, Keating CP. Peripheral nerve reconstruction after injury: A review of clinical and experimental therapies. Biomed. Res. Int. 2014;1&#x2013;13:2014. doi: 10.1155/2014/698256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/698256</ArticleId><ArticleId IdType="pmc">PMC4167952</ArticleId><ArticleId IdType="pubmed">25276813</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, et al. A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. Hum. Mol. Genet. 1994 doi: 10.1093/hmg/3.6.981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/3.6.981</ArticleId><ArticleId IdType="pubmed">7951249</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed M, et al. Age and founder effect of S0D1 A4V mutation causing ALS. Neurology. 2009 doi: 10.1212/01.wnl.0000343509.76828.2a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000343509.76828.2a</ArticleId><ArticleId IdType="pmc">PMC2683645</ArticleId><ArticleId IdType="pubmed">19176896</ArticleId></ArticleIdList></Reference><Reference><Citation>Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T. Prognosis in familial amyotrophic lateral sclerosis: Progression and survival in patients with glu100gly and ala4val mutations in Cu, Zn superoxide dismutase. Neurology. 1997 doi: 10.1212/WNL.48.1.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.48.1.55</ArticleId><ArticleId IdType="pubmed">9008494</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G, et al. Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients. Ann. Clin. Transl. Neurol. 2015 doi: 10.1002/acn3.179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.179</ArticleId><ArticleId IdType="pmc">PMC4402082</ArticleId><ArticleId IdType="pubmed">25909082</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal A, Nicholson G. Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation. J. Neurol. Neurosurg. Psychiatry. 2002 doi: 10.1136/jnnp.73.2.199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.73.2.199</ArticleId><ArticleId IdType="pmc">PMC1737965</ArticleId><ArticleId IdType="pubmed">12122184</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal A, Nicholson G. Normal complement of motor units in asymptomatic familial (SOD1 mutation) amyotrophic lateral sclerosis carriers. J. Neurol. Neurosurg. Psychiatry. 2001 doi: 10.1136/jnnp.71.4.478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.71.4.478</ArticleId><ArticleId IdType="pmc">PMC1763514</ArticleId><ArticleId IdType="pubmed">11561030</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocci T, et al. Differential motor neuron impairment and axonal regeneration in sporadic and familiar amyotrophic Lateral Sclerosis with SOD-1 mutations: Lessons from neurophysiology. Int. J. Mol. Sci. 2011 doi: 10.3390/ijms12129203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms12129203</ArticleId><ArticleId IdType="pmc">PMC3257125</ArticleId><ArticleId IdType="pubmed">22272128</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Wuu J. Presymptomatic studies in ALS: Rationale, challenges, and approach. Neurology. 2012 doi: 10.1212/WNL.0b013e31826e9b1d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31826e9b1d</ArticleId><ArticleId IdType="pmc">PMC3468777</ArticleId><ArticleId IdType="pubmed">23071166</ArticleId></ArticleIdList></Reference><Reference><Citation>Jokela M, et al. Distinct muscle biopsy findings in genetically defined adult-onset motor neuron disorders. PLoS ONE. 2016 doi: 10.1371/journal.pone.0151376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0151376</ArticleId><ArticleId IdType="pmc">PMC4801364</ArticleId><ArticleId IdType="pubmed">26999347</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajbhandari L, et al. Toll-like receptor 4 deficiency impairs microglial phagocytosis of degenerating axons. Glia. 2014 doi: 10.1002/glia.22719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22719</ArticleId><ArticleId IdType="pubmed">25042766</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurapati S, et al. Role of the JNK pathway in varicella-zoster virus lytic infection and reactivation. J. Virol.. 2017 doi: 10.1128/jvi.00640-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00640-17</ArticleId><ArticleId IdType="pmc">PMC5553188</ArticleId><ArticleId IdType="pubmed">28637759</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosmane S, Yang IH, Ruffin A, Thakor N, Venkatesan A. Circular compartmentalized microfluidic platform: Study of axon&#x2013;glia interactions. Lab Chip. 2010;10:741. doi: 10.1039/b918640a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/b918640a</ArticleId><ArticleId IdType="pubmed">20221562</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 2019 doi: 10.1038/s41593-018-0293-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0293-z</ArticleId><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 2019 doi: 10.1038/s41593-018-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0300-4</ArticleId><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor AM, et al. A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat. Methods. 2005 doi: 10.1038/nmeth777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth777</ArticleId><ArticleId IdType="pmc">PMC1558906</ArticleId><ArticleId IdType="pubmed">16094385</ArticleId></ArticleIdList></Reference><Reference><Citation>Garone MG, et al. ALS-related FUS mutations alter axon growth in motoneurons and affect HuD/ELAVL4 and FMRP activity. Commun. Biol. 2021 doi: 10.1038/s42003-021-02538-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02538-8</ArticleId><ArticleId IdType="pmc">PMC8410767</ArticleId><ArticleId IdType="pubmed">34471224</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoklund Dittlau K, et al. Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition. Stem Cell Rep. 2021;16:2213&#x2013;2227. doi: 10.1016/j.stemcr.2021.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.03.029</ArticleId><ArticleId IdType="pmc">PMC8452598</ArticleId><ArticleId IdType="pubmed">33891869</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadaoka T, et al. In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency. Proc. Natl. Acad. Sci. 2016 doi: 10.1073/pnas.1522575113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1522575113</ArticleId><ArticleId IdType="pmc">PMC4855584</ArticleId><ArticleId IdType="pubmed">27078099</ArticleId></ArticleIdList></Reference><Reference><Citation>Taga A, et al. Establishment of an electrophysiological platform for modeling ALS with regionally-specific human pluripotent stem cell-derived astrocytes and neurons. J. Vis. Exp. 2021 doi: 10.3791/62726.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/62726</ArticleId><ArticleId IdType="pmc">PMC9169687</ArticleId><ArticleId IdType="pubmed">34515684</ArticleId></ArticleIdList></Reference><Reference><Citation>Taga A, et al. Role of human-induced pluripotent stem cell-derived spinal cord astrocytes in the functional maturation of motor neurons in a multielectrode array system. Stem Cells Transl. Med. 2019 doi: 10.1002/sctm.19-0147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.19-0147</ArticleId><ArticleId IdType="pmc">PMC6877769</ArticleId><ArticleId IdType="pubmed">31631575</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulting GL, et al. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 2011 doi: 10.1038/nbt.1783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1783</ArticleId><ArticleId IdType="pmc">PMC3229307</ArticleId><ArticleId IdType="pubmed">21293464</ArticleId></ArticleIdList></Reference><Reference><Citation>Roybon L, et al. Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes. Cell Rep. 2013 doi: 10.1016/j.celrep.2013.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.021</ArticleId><ArticleId IdType="pmc">PMC4229657</ArticleId><ArticleId IdType="pubmed">23994478</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasques JF, Mendez-Otero R, Gubert F. Modeling ALS using iPSCs: Is it possible to reproduce the phenotypic variations observed in patients in vitro? Regen. Med. 2020 doi: 10.2217/rme-2020-0067.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/rme-2020-0067</ArticleId><ArticleId IdType="pubmed">32795164</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim BW, Ryu J, Jeong YE, Kim J, Martin LJ. Human motor neurons with SOD1-G93A mutation generated from CRISPR/Cas9 gene-edited iPSCs develop pathological features of amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2020 doi: 10.3389/fncel.2020.604171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.604171</ArticleId><ArticleId IdType="pmc">PMC7710664</ArticleId><ArticleId IdType="pubmed">33328898</ArticleId></ArticleIdList></Reference><Reference><Citation>Shlevkov E, et al. A high-content screen identifies TPP1 and aurora B as regulators of axonal mitochondrial transport. Cell Rep. 2019;28:3224&#x2013;3237.e3225. doi: 10.1016/j.celrep.2019.08.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.08.035</ArticleId><ArticleId IdType="pmc">PMC6937139</ArticleId><ArticleId IdType="pubmed">31533043</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, et al. All-optical electrophysiology for high-throughput functional characterization of a human iPSC-derived motor neuron model of ALS. Stem Cell Rep. 2018 doi: 10.1016/j.stemcr.2018.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.04.020</ArticleId><ArticleId IdType="pmc">PMC5993648</ArticleId><ArticleId IdType="pubmed">29779896</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, et al. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell. 2014;14:796&#x2013;809. doi: 10.1016/j.stem.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.02.004</ArticleId><ArticleId IdType="pmc">PMC4230530</ArticleId><ArticleId IdType="pubmed">24704493</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhinge A, Namboori SC, Zhang X, VanDongen AMJ, Stanton LW. Genetic correction of SOD1 mutant iPSCs reveals ERK and JNK activated AP1 as a driver of neurodegeneration in amyotrophic lateral sclerosis. Stem Cell Rep. 2017 doi: 10.1016/j.stemcr.2017.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.02.019</ArticleId><ArticleId IdType="pmc">PMC5390134</ArticleId><ArticleId IdType="pubmed">28366453</ArticleId></ArticleIdList></Reference><Reference><Citation>Osking Z, et al. ALS-linked SOD1 mutants enhance neurite outgrowth and branching in adult motor neurons. iScience. 2019 doi: 10.1016/j.isci.2018.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2018.12.026</ArticleId><ArticleId IdType="pmc">PMC6708981</ArticleId><ArticleId IdType="pubmed">31425915</ArticleId></ArticleIdList></Reference><Reference><Citation>Grenningloh G, Soehrman S, Bondallaz P, Ruchti E, Cadas H. Role of the microtubule destabilizing proteins SCG10 and stathmin in neuronal growth. J. Neurobiol. 2004 doi: 10.1002/neu.10279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/neu.10279</ArticleId><ArticleId IdType="pubmed">14598370</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp PS, Tyreman N, Jones KE, Gordon T. 2018. Crush injury to motor nerves in the G93A transgenic mouse model of amyotrophic lateral sclerosis promotes muscle reinnervation and survival of functionally intact nerve-muscle contacts. Neurobiol. Dis.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.01.019</ArticleId><ArticleId IdType="pubmed">29409912</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Park HS, Hong S, Kang S. Motor neurons derived from ALS-related mouse iPS cells recapitulate pathological features of ALS. Exp. Mol. Med. 2016 doi: 10.1038/emm.2016.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2016.113</ArticleId><ArticleId IdType="pmc">PMC5192071</ArticleId><ArticleId IdType="pubmed">27932790</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng B, et al. Progressive degeneration and inhibition of peripheral nerve regeneration in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Cell. Physiol. Biochem. 2018 doi: 10.1159/000489627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000489627</ArticleId><ArticleId IdType="pubmed">29742495</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesnard NA, Haulcomb MM, Tanzer L, Sanders VM, Jones KJ. Delayed functional recovery in presymptomatic mSOD1G93A mice following facial nerve crush axotomy. J. Neurodegener. Regen. 2013 doi: 10.5055/jndr.2013.0009.</Citation><ArticleIdList><ArticleId IdType="doi">10.5055/jndr.2013.0009</ArticleId><ArticleId IdType="pmc">PMC3963697</ArticleId><ArticleId IdType="pubmed">24672589</ArticleId></ArticleIdList></Reference><Reference><Citation>Schram S, et al. Mutant SOD1 prevents normal functional recovery through enhanced glial activation and loss of motor neuron innervation after peripheral nerve injury. Neurobiol. Dis. 2019 doi: 10.1016/j.nbd.2018.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.12.020</ArticleId><ArticleId IdType="pubmed">30594811</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AR, Muke I, Bobylev I, Lehmann HC. ROCK inhibition improves axonal regeneration in a preclinical model of amyotrophic lateral sclerosis. J. Comp. Neurol. 2019 doi: 10.1002/cne.24679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.24679</ArticleId><ArticleId IdType="pubmed">30861116</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallon C, Russell KA, Sakhalkar S, Andrapallayal N, Farah MH. Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice. Neuroscience. 2016;312:179&#x2013;189. doi: 10.1016/j.neuroscience.2015.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.11.018</ArticleId><ArticleId IdType="pmc">PMC4691388</ArticleId><ArticleId IdType="pubmed">26592719</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 2019 doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauvin S, Sobel A. Neuronal stathmins: A family of phosphoproteins cooperating for neuronal development, plasticity and regeneration. Prog. Neurobiol. 2015 doi: 10.1016/j.pneurobio.2014.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2014.09.002</ArticleId><ArticleId IdType="pubmed">25449700</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat. Med. 2018 doi: 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Seijffers R, Mills CD, Woolf CJ. ATF3 increases the intrinsic growth state of DRG neurons to enhance peripheral nerve regeneration. J. Neurosci. 2007;27:7911&#x2013;7920. doi: 10.1523/jneurosci.5313-06.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.5313-06.2007</ArticleId><ArticleId IdType="pmc">PMC6672733</ArticleId><ArticleId IdType="pubmed">17652582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma CHE, et al. Accelerating axonal growth promotes motor recovery after peripheral nerve injury in mice. J. Clin. Investig. 2011 doi: 10.1172/JCI58675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI58675</ArticleId><ArticleId IdType="pmc">PMC3223863</ArticleId><ArticleId IdType="pubmed">21965333</ArticleId></ArticleIdList></Reference><Reference><Citation>Costigan M, et al. Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. BMC Neurosci. 2002;3:16. doi: 10.1186/1471-2202-3-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-3-16</ArticleId><ArticleId IdType="pmc">PMC139981</ArticleId><ArticleId IdType="pubmed">12401135</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin JW, Pan B, Polley MA, Hoffman PN, Farah MH. Measuring nerve regeneration in the mouse. Exp. Neurol. 2010;223:60&#x2013;71. doi: 10.1016/j.expneurol.2009.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2009.12.033</ArticleId><ArticleId IdType="pubmed">20080088</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulaiman WA, Kline DG. Nerve surgery: A review and insights about its future. Clin. Neurosurg. 2006;53:38&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">17380737</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon T, et al. Accelerating axon growth to overcome limitations in functional recovery after peripheral nerve injury. Neurosurgery. 2009;65:A132&#x2013;A144. doi: 10.1227/01.neu.0000335650.09473.d3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/01.neu.0000335650.09473.d3</ArticleId><ArticleId IdType="pubmed">19927058</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J, Aguila J, Hoogstraaten R, Kee N, Hedlund E. Axon-seq decodes the motor axon transcriptome and its modulation in response to ALS. Stem Cell Rep. 2018 doi: 10.1016/j.stemcr.2018.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.11.005</ArticleId><ArticleId IdType="pmc">PMC6294264</ArticleId><ArticleId IdType="pubmed">30540963</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>